Creative Medical Technology Holdings, INC. (CELZ) — DEF 14A Filings

All DEF 14A filings from Creative Medical Technology Holdings, INC.. Browse 5 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (5)

CELZ Seeks Shareholder Nod for 2.79M Warrant Exercise Amid Dilution Fears — Nov 13, 2025 Risk: medium
Creative Medical Technology Holdings, Inc. (CELZ) is holding a Special Meeting on December 26, 2025, to seek stockholder approval for the exercise in full of 2,
CELZ Sets Dec. 18 Annual Meeting; Board Backs All Proposals — Oct 30, 2025 Risk: low
Creative Medical Technology Holdings, Inc. (CELZ) is holding its 2025 Annual Meeting of Stockholders on December 18, 2025, at 9:00 a.m. Pacific Standard Time in
Creative Medical Tech Holdings Files Definitive Proxy Statement — Mar 17, 2025 Risk: low
Creative Medical Technology Holdings, Inc. filed a Definitive Proxy Statement (DEF 14A) on March 17, 2025, for the fiscal year ending December 31, 2024. The com
Creative Medical Tech Files Definitive Proxy Statement — Nov 4, 2024 Risk: low
Creative Medical Technology Holdings, Inc. filed an amendment to its Schedule 14A on November 4, 2024, for its definitive proxy statement. The company, previous
Creative Medical Technology Holdings Files Proxy Statement — Jun 5, 2024 Risk: medium
Creative Medical Technology Holdings, Inc. filed its definitive proxy statement on June 5, 2024, for its annual meeting on July 19, 2024. The company, formerly

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX